Synthetic Biologics (SYN) Jumps: Stock Up 5.2%

Zacks Equity Research
January 3, 2014

Synthetic Biologics Inc. (SYN) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the healthcare stock since Dec 16, as it is now up 61%.
 
In the last 30 days, the company has witnessed a negative estimate revision, while the Zacks Consensus Estimate moved higher. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
 
Synthetic Biologics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked medical stocks include Heska Corporation (HSKA), Coronado Biosciences, Inc. (CNDO) and Gentium S.p.A (GENT). All three companies carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




SYNTHETIC BIOLOGICS INC (SYN): Free Stock Analysis Report

CORONADO BIOSCIENCES INC (CNDO): Free Stock Analysis Report

GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report

HESKA CORP (HSKA): Free Stock Analysis Report


Zacks Investment Research